Reunion Neuroscience News and Activities

Reunion Neuroscience is a company listed under the stock ticker REUN (US).

Acquisition, funding and merger involving Reunion Neuroscience.

• Reunion Neuroscience has just announced a $103 Million fundraising (posted on August 8 2025).

View the org chart displaying its 13 main executives

Most searched biographies at Reunion Neuroscience

• Greg Mayes, President and Chief Executive Officer
• Ellen Lubman, Board Member
• Michael Ehlers, Director

Create your alert
to follow the executive moves at Reunion Neuroscience.

Reunion Neuroscience has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Reunion Neuroscience

Social media about Reunion Neuroscience

• Reunion Neuroscience on Wikipedia, Google News & Yahoo Finance
• Reunion Neuroscience on LinkedIn, X (Twitter) & YouTube